Mapping large numbers of results may take a few moments.
|Company APIE Therapeutics Inc.||Activity: Research and Development||Company Description
APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies.
|Company Applied Catheter Technologies Inc.||Activity: Research and Development||Company Description Applied Catheter Technologies develops drug-coated medical devices that inhibit scar formation. The company's first products under development are catheters for male urethral stricture and devices that inhibit abdominal adhesions.||Location Winston-Salem|
|Company Avior Inc.||Activity: Research and Development||Company Description Avior is developing a nanoparticle-based drug delivery technology to deliver lipophilic drugs with high bioavailability. It is testing its technology using a molecule for the treatment of pruritus in chronic kidney disease.||Location Durham|
|Company Baxter Healthcare Corp.||Activity: Production and Manufacturing||Company Description Baxter's facility in Marion produces intravenous and peritoneal dialysis solutions, as well as empty containers and component parts for other Baxter facilities.||Location Marion|
|Company BD Technologies and Innovation||Activity: Research and Development||Company Description BD Technologies and Innovation develops technologies for parenteral drug delivery, advanced diagnostics, smart medical devices and genomic research and supports external innovation. The RTP site is BD's corporate technology R&D and innovation center.||Location Research Triangle Park|
|Company Clinipace||Activity: Contract Research and Testing||Company Description Clinipace provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease.||Location Morrisville|
|Company Cosette Pharmaceuticals||Activity: Production and Manufacturing||Company Description Cosette Pharmaceuticals manufactures OTC and prescription hydrocortisone, antifungal and permethrin products such as creams, ointments, liquids and suppositories.||Location Lincolnton|
|Company Dignify Therapeutics LLC||Activity: Research and Development||Company Description Dignify Therapeutics develops bladder and bowel drug therapies for spinal cord-injured, multiple sclerosis and similar patient populations with voiding dysfunction.||Location Research Triangle Park|
|Company Endacea Inc.||Activity: Research and Development||Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for renal impairment and inflammation, including sepsis and asthma.||Location Research Triangle Park|
|Company Hammock Pharmaceuticals Inc.||Activity: Research and Development||Company Description Hammock Pharmaceuticals licenses and develops women's health and urology products. It is developing a metronidazole and clindamycin vaginal gel for the treatment of bacterial vaginosis, and a urology product for the treatment of radiation cystitis.||Location Charlotte|
|Company MD Scientific LLC||Activity: Research and Development||Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents.||Location Charlotte|
|Company NovaTarg Inc.||Activity: Research and Development||Company Description NovaTarg discovers and develops new medicines to treat metabolic diseases and cancer.||Location Research Triangle Park|
|Company Praetego Inc.||Activity: Research and Development||Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes in conditions and diseases related to glucose dysregulation. Its primary focus is serious diabetic complications, and lead indication is Peripheral Neuropathy.||Location Research Triangle Park|
|Company Roivant Sciences Inc.||Activity: Research and Development||Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease.||Location Durham|
|Company Twin City Bio LLC||Activity: Production and Manufacturing||Company Description Twin City Bio manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs.||Location Winston-Salem|
|Company URO-1 Inc.||Activity: Research and Development||Company Description
URO-1 develops breakthrough products for office procedures for urology and urogynecology, which support clinical outcomes, patient experience and procedure efficiency.
|Company Urovant Sciences Inc.||Activity: Research and Development||Company Description Urovant Sciences develops and commercializes therapies for urologic conditions.||Location Durham|
|Company Veloxis Pharmaceuticals Inc.||Activity: Sales and Operations||Company Description Veloxis Pharmaceuticals is focused on the commercialization of ENVARSUS XR (tacrolimus extended-release tablets) based upon the company’s patented delivery technology, MeltDose.||Location Cary|